FZ-AD005 is a DLL3-targeted ADC composed of the novel anti-DLL3 antibody FZ-A038 and a valine-alanine (Val-Ala) dipeptide linker. This compound is used for research in small cell lung cancer.
Molecular Weight:
406.28
Formula:
C16H12F6N4O2
Target:
Antibody-Drug Conjugates (ADCs)
T9901A-239
* VAT and and shipping costs not included. Errors and price changes excepted